Loading...
XSHE
002872
Market cap228mUSD
Dec 05, Last price  
5.09CNY
1D
0.79%
1Q
8.76%
IPO
-78.14%
Name

Tiansheng Pharmaceutical Group Co Ltd

Chart & Performance

D1W1MN
XSHE:002872 chart
P/E
P/S
2.84
EPS
Div Yield, %
Shrs. gr., 5y
Rev. gr., 5y
-19.43%
Revenues
570m
-1.66%
1,004,120,0191,421,960,0591,663,784,3431,843,015,2802,086,931,5572,261,414,3762,171,439,9231,678,052,4661,202,746,111736,685,771606,992,213579,334,659569,712,742
Net income
-87m
L-6.09%
109,987,794125,948,051164,573,145191,977,863224,496,958248,575,37615,621,1870000-93,073,691-87,403,826
CFO
50m
P
145,057,10057,059,300191,988,710213,538,862506,677,2400153,986,687144,208,286189,754,32918,971,79289,184,806-24,561,76150,146,536
Dividend
Aug 22, 20180.236 CNY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Tiansheng Pharmaceutical Group Co., Ltd. engages in the pharmaceutical manufacturing and circulation activities. It offers products in various categories, including respiratory, digestive, cardiovascular and cerebrovascular, pediatric, gynecological, orthopedic, tumor, hepatobiliary, blood, surgery, diabetes, and others. The company was founded in 2001 and is based in Chongqing, China.
IPO date
May 19, 2017
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT